Sort Results:

List of News


  • AstraZeneca Neuroscience Unit Inks Pact With Vanderbilt University

  • Date: 14 January 2013
  • AstraZeneca plc (NYSE: AZN) has signed a research deal with Vanderbilt University to identify potential treatments for psychosis and other psychiatric symptoms associated with diseases like Alzheimer’s and schizophrenia. The UK-based drug...